12.3.2 Oropharyngeal anti-infective drugs

All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.

Switch to S&W website

Formulary

Back

12.3 Drugs acting on the oropharynx Toggle Pages

12.3.1 Oral ulceration and inflammation 12.3.2 Oropharyngeal anti-infective drugs 12.3.4 Mouthwashes, gargles, and dentifrices 12.3.5 Treatment of dry mouth

Chapter 12: Ear, nose & oropharynx Toggle Parent Pages

Treatment of allergic rhinitis Post radiotherapy treatments 12.1 Drugs acting on the ear 12.2 Drugs acting on the nose 12.3 Drugs acting on the oropharynx 12.4 Miscellaneous aural devices and preparations

Print this page

12.3.2 Oropharyngeal anti-infective drugs

First Line

Second Line

Specialist

Hospital Only

For guidance on the management of oral candidiasis in palliative care see 16.10 Mouth care in palliative care.

Nystatin

Oral suspension 100,000units/ml (£1.80 = 30ml)

Indications

Oral candidiasis

Miconazole

Oromucosal gel sugar free 20mg/g (£5.26 = 15g)

Indications

Oral candidiasis

Notes

Miconazole greatly enhances the anti-coagulation effect of warfarin, avoid concomitant use. Refer also to MHRA Drug Safety Update June 2016.
Refer to the BNF or manufacturer's Summary of Product Characteristics (SPC) for a full list of interactions with miconazole.

Oral fluconazole may be considered following failure or contraindication to topical treatments see 5.2.1 Triazole antifungals